BAJAJ FINSERV DIRECT LIMITED
Latest IPO Information

CORONA Remedies Ltd. IPO

IPO Date: Dec 8 to Dec 10 2025

Listing Date: Dec 15 2025

Objective


IPO Details

Face Value ₹ 10.00 Per Share
Issue Size ₹ 460.85 - 485.53 Cr
Price Band ₹ 1008.00 - ₹ 1062.00 Per Share
Market LOT 14 shares
Issue Type Book building

About Company

We are an India-focused branded pharmaceutical formulation company engaged in developing, manufacturingand marketing products in women’s healthcare, cardio-diabeto, pain management, urology and other therapeuticareas. According to the Industry Report, we are the second fastest growing company among the top 30 companiesin the Indian Pharmaceutical Market (“IPM”) in terms of domestic sales between MAT December 2021 and MAT December 2024. During this period, our domestic sales grew at a CAGR of 19.90%, compared to the IPM whichgrew at a CAGR of 8.79%, displaying a growth of more than 2.25 times t .... he IPM’s growth (Source: IndustryReport). This has been driven by our growth in volume (at an average of 9.58% over the above period, comparedto the IPM’s growth of 1.65%), and new product launches (at an average of 3.91% over the above period,compared to the IPM’s growth of 1.68%) Read More
Address

C – Mondeal Business Park Near Gurudwara, S. G. Highway Thaltej

City

Ahmedabad

State

Gujarat

Pincode

380059

Phone

079 4023 3000

Email

complianceofficer@coronaremedies.com

Website

www.coronaremedies.com

About IPO

Listed At BSE/NSE
Lead Manager Kotak Mahindra Capital Co Ltd
Promoters
Ankur Kirtikumar Mehta
Kirtikumar Laxmidas Mehta
Niravkumar Kirtikumar Mehta

Promoter's Holding

Registrar

Bigshare Services Pvt Ltd

91-022-62638200
Investor@bigshareonline.com

Latest News

May
19
2026
EQUITY Posted on May 19th 2026

Corona Remedies informs about conference call

Pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Corona Remedies has informed that the Officials of the Company will be attending Investor Conferences as on May 26, 2026, and May 27, 2026.
The above information is a part of company’s filings submitted to BSE.
Read More
May
21
2026
FINANCE Posted on May 21st 2026

Currency futures for May expiry trade stronger with 6.21% increase in OI

The partially convertible rupee is currently trading at 96.28, stronger compared to its Wednesday’s close at 96.86. The rupee opened at 96.25 and touched day’s high of 96.45 and low of 96.05.
The May currency futures were trading at 96.23 with a spread of 0.0050 and a volume of 4,49,250. The contract opened at 96.35 stronger from its previous closing of 96.8075. The open interest (OI) stood at 28,93,339 up by 6.21% compared to its previous close of 27,24,290.
Read More
May
21
2026
EQUITY Posted on May 21st 2026

Shri Bajrang Alliance informs about updates

Shri Bajrang Alliance has informed that pursuant to NSE Circular Ref. No. 0645/2026 dated April 17, 2026, the equity shares of Bajrang Alliance (Symbol: SHBAJRG, ISIN: INE402H01015) have been admitted to dealings and permitted to trade on the National Stock Exchange of India platform with effect from April 20, 2026. The aforesaid information has been noted by the Company through publicly available records/circulars issued by NSE. The Company is presently undertaking necessary operational coordination and correspondence with the concerned authorities/exchanges in this regard.
The above information is a part of company’s filings submitted to BSE.
Read More
May
21
2026
EQUITY Posted on May 21st 2026

Varroc Engineering informs about conference call

Pursuant to Regulation 30 read with Schedule III of the Listing Regulations, Varroc Engineering has informed that a conference call with Analysts/investors has been scheduled on Wednesday, May 27, 2026, at 5:00 pm (IST) to discuss the Audited Financial Results of the Company for the quarter and year ended on March 31, 2026. Con-call invite is annexed.

The above information is a part of company’s filings submitted to BSE.

Read More
May
21
2026
EQUITY Posted on May 21st 2026

Mohit Paper Mills informs about secretarial compliance report

Pursuant to Regulation 24A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended from time to time, Mohit Paper Mills has informed that it enclosed the Annual Secretarial Compliance Report dated May 19, 2026 of the company for the Financial Year ended March 31, 2026, duly signed & issued by Ankit J & Associates, Company Secretaries. The above information will also be made available on the website of the Company at www.mohitpaper.in

The above information is a part of company’s filings submitted to BSE.

Read More
no-content No Records Found

Sign in to Unlock Offers!

Explore Loans, Cards, Investments & Insurance

No SPAM We don't SPAM
Right Hand Side Image
STEP 1/2

Open Demat Account today!

+91

Enter mobile number

Invalid mobile number

Enter Full Name

Invalid Full Name

Verification required
close

Enter the One Time Password (OTP)

Sent to ********99

Edit Number
Enter valid OTP
Field should not be blank
You have exhausted your OTP attempts try again after 10 min

Request another in 60s

Resend OTP

secure   100% safe and secure

Frequently Asked Questions

What is the issue size of CORONA Remedies Ltd. IPO?

The issue size of CORONA Remedies Ltd. IPO is ₹460.85 - 485.53 crore.

The CORONA Remedies Ltd. IPO opens for subscription on 2025-12-08 and closes on 2025-12-10.

The price range of CORONA Remedies Ltd. IPO is ₹1,008.00 to ₹1,062.00.

The lot size of CORONA Remedies Ltd. IPO is 14 shares.

The registrar of CORONA Remedies Ltd. IPO is Bigshare Services Pvt Ltd .

CORONA Remedies Ltd. IPO will be listed on BSE/NSE .

You will typically receive a confirmation message or notification from your broker or trading platform shortly after placing your IPO order. This confirms that your application has been submitted successfully. You can also check the order status in the IPO section of your trading account or app.

Apply early with valid UPI and PAN before 2025-12-10 to increase your chances.

The listing date of CORONA Remedies Ltd. IPO is 2025-12-15.

An Initial Public Offering (IPO) is when a private company sells shares to the public for the first time, enabling investors to purchase these shares and gain partial ownership in the business. For instance, if a well-known tech firm wants to grow and requires additional funds, it might choose to go public through an IPO. During this process, investors can buy shares, and the company’s stock starts trading on the stock exchange on the day of the IPO listing.

Investors can apply for an IPO through their bank or brokerage account. Many trading platforms have a specific section for IPOs where users can submit their applications online.

The primary market is where shares are offered to the public for the first time via an IPO. After the IPO, shares are traded on the secondary market (stock exchange), where existing shareholders can sell to new buyers.

Investing in an IPO offers the opportunity to become an early investor in companies with high growth potential, at a price which may be lower than their post-listing market value. It provides a chance to participate in the company's growth journey from its early stages. However, IPO investments also come with inherent risks, such as market volatility and uncertainties about the company's future performance.

The price of an IPO is established through a systematic process known as "book building." In this method, investors bid within a given price range, and the final price is set based on demand and market conditions. Several factors play a crucial role in determining the IPO price, including:

Past Financial Performance: Evaluating the company's revenue, profits, and financial stability over time

Growth Potential: Assessing future prospects based on the company's business model and market opportunities

Industry Peers: Comparing valuation metrics with similar companies in the same sector

Larger Industry Picture: Analysing overall industry trends and economic conditions that could impact the company's performance

The lock-in period for IPO shares refers to a duration during which specific investors are restricted from selling their shares post-listing. This period varies based on the type of investor:

Promoters: The lock-in period for promoters ranges from 6 months to 18 months, ensuring their commitment to the company's long-term growth

Anchor Investors: Typically, anchor investors face a shorter lock-in period of 30 to 90 days, depending on regulatory norms and the specific IPO

IPOs can be volatile and may not perform as expected in the short term. Investors risk losing capital if the stock price drops after listing, especially if the company does not meet its growth projections.

Information on upcoming IPOs is often available through brokerage platforms, financial news sites, and regulatory bodies like SEBI, which publishes details on companies going public. You can also get these details under the upcoming IPO section on Bajaj Markets.

Eligibility for an IPO typically includes:

Retail Investors: Individuals who invest in smaller amounts, usually under the “retail investor” category, with certain limits

Qualified Institutional Buyers (QIBs): Entities like mutual funds, banks, and insurance companies, who invest large sums

Non-Institutional Investors (NIIs): High-net-worth individuals or entities investing above the retail threshold

Investors must have a Demat and trading account to apply, and in some cases, certain financial or residency qualifications may apply depending on local regulations.

SME (Small and Medium Enterprise) IPOs generally carry higher risk but may provide significant growth potential. Investors should research the company’s stability, financials, and sector risks, as SME stocks can be more volatile compared to large-cap companies.

View More

Invalid Mobile Number

Invalid Full Name

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform. 

Home
Home
ONDC_Shopping
Shopping
Loan
Loan Offers
My Accounts
My Accounts
Explore
Explore